Calamos Advisors LLC Repligen Corp Transaction History

Calamos Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$140.68 - $188.02 $328,206 - $438,650	-2,333 Closed	0 $0
Q1 2022 May 03, 2022	SELL	$161.19 - $257.96 $1.02 Million - $1.63 Million	-6,338 Reduced 73.09%	2,333 $439,000
Q4 2021 Feb 01, 2022	BUY	$247.59 - $304.47 $848,490 - $1.04 Million	3,427 Added 65.35%	8,671 $2.3 Million
Q3 2021 Oct 26, 2021	BUY	$194.77 - $324.21 $566,196 - $942,478	2,907 Added 124.39%	5,244 $1.52 Million
Q2 2021 Jul 22, 2021	SELL	$165.87 - $220.95 $2.16 Million - $2.88 Million	-13,037 Reduced 84.8%	2,337 $467,000
Q1 2021 Apr 12, 2021	SELL	$180.37 - $226.26 $48,699 - $61,090	-270 Reduced 1.73%	15,374 $2.99 Million
Q4 2020 Jan 27, 2021	BUY	$148.08 - $206.57 $415,512 - $579,635	2,806 Added 21.86%	15,644 $3 Million
Q3 2020 Oct 26, 2020	BUY	$122.51 - $158.27 $215,495 - $278,396	1,759 Added 15.88%	12,838 $1.89 Million
Q2 2020 Jul 27, 2020	BUY	$94.33 - $140.48 $1.05 Million - $1.56 Million	11,079 New	11,079 $1.37 Million
Q4 2019 Jan 15, 2020	SELL	$73.84 - $93.08 $590,350 - $744,174	-7,995 Closed	0 $0
Q3 2019 Oct 21, 2019	BUY	$76.65 - $95.51 $612,816 - $763,602	7,995 New	7,995 $613,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.